Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Consta and Skills Training in Schizophrenia
NCT00148083Phase 3Completed
- Sponsor
- University of Illinois Chicago
- Start
- Sep 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by University of Illinois Chicago. Started Sep 2005; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00148083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148083.